Flovent and Zoledronic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent (fluticasone propionate) and Zoledronic (zoledronic acid). Common drug interactions include atrial fibrillation among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Flovent and Zoledronic. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Flovent?

Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

On Jul, 15, 2026

50 people who take Flovent and Zoledronic together, and have interactions are studied.

Flovent and Zoledronic drug interactions.

What are the common drug interactions of Flovent and Zoledronic, by gender? *:

female:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bacterial infection
Bone density decreased
Bone disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Chronic fatigue syndrome (disorder that causes extreme fatigue)
Cyst (a closed sac)
Decreased activity
Dental fistula

male:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Drug hypersensitivity
Dyspnoea exertional (breathlessness or shortness of breath)
Hot flush (sudden feelings of heat)
Oedema peripheral (superficial swelling)
Oxygen saturation decreased
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Weight increased
Blood pressure fluctuation

What are the common drug interactions of Flovent and Zoledronic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Pseudomonas test positive
Pulmonary cavitation (cavity in the lung)

50-59:

Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Plasma cell myeloma (cancer that begins in plasma cells)
Thrombosis (formation of a blood clot inside a blood vessel)
Lung infection
Respiratory rate increased (excess breathing rate/min)
Abdominal pain
Bacterial infection
Bone density decreased
Bone disorder

60+:

Oedema (fluid collection in tissue)
Pain in extremity
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Laryngitis (inflammation of the larynx)
Limb injury
Loss of proprioception (loss of senses of body and parts)
Nasal oedema (fluid collection in nose)
Nasal septum deviation (deviated nasal septum)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 12 people, 24.00%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 12 people, 24.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 9 people, 18.00%
Pain: 8 people, 16.00%
Osteoporosis (bones weak and more likely to break): 8 people, 16.00%
Back Pain: 7 people, 14.00%
Dry Eyes (lack of adequate tears): 7 people, 14.00%
Essential Thrombocythaemia (chronic blood cancer): 7 people, 14.00%
Neuropathy Peripheral (surface nerve damage): 7 people, 14.00%
Allergic Rhinitis: 7 people, 14.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent and Zoledronic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously